Your Current Position: NEWS
-
【Company News】 Converd forms a partnership with China Resources (CR Pharmaceutical) in developing oncolytic virus therapy platform2017-12-15Converd has received investment in shares from CR Pharmaceutical(华润生命科学). This is a part of Converd’s B series financing, which also includes investments from Nanjing Jingyong Healthcare Capitals.
-
Professor Gao Daiqing came to our company for academic exchange on clinical research of immunotherapy.
-
【Company News】 Converd settled in Zhejiang Overseas High-Level Talents Innovation Park, Zhangjiang Hangzhou Future SCI-Tech City2015-10-13For further development, in February 2012, ConVerd registered HangzhouConVerd Co., Ltd. in Zhangjiang Hangzhou Future SCI-Tech City.
-
2015-07-23In July 2009, Suzhou Converd Co., Ltd. was founded in Kunshan Small Nucleic Acid Base, Suzhou, Jiangsu.
-
After one year of development, ConVerd won the investment of Hong Kong Morningside Venture Capital Group